Labajo, Lemuel Mar A.

HRN: 17-06-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/14/2024
03/21/2024
IV DRIP
2.25g
Q6h
Sepsis Sec To Typhoid Ileitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: